UNLIMITED FREE
ACCESS TO THE WORLD'S BEST IDEAS

SUBMIT
Already a GlobalSpec user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your GlobalSpec Experience

Select Your Free Newsletters

Industry Newsletters

Select Your Free Product Alerts

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI M59

Epidemiological Cutoff Values for Antifungal Susceptibility Testing

inactive
Buy Now
Organization: CLSI
Publication Date: 1 January 2018
Status: inactive
Page Count: 28
scope:

This document includes epidemiological cutoff values and quality control tables developed according to criteria provided in the Clinical and Laboratory Standards Institute guideline M57.

Document History

CLSI M59
June 1, 2020
Epidemiological Cutoff Values for Antifungal Susceptibility Testing
Clinical and Laboratory Standards Institute document M59—Epidemiological Cutoff Values for Antifungal Susceptibility Testing includes epidemiological cutoff values (ECVs) and quality control tables...
CLSI M59
January 1, 2018
Epidemiological Cutoff Values for Antifungal Susceptibility Testing
This document includes epidemiological cutoff values and quality control tables developed according to criteria provided in the Clinical and Laboratory Standards Institute guideline M57.
CLSI M59
April 1, 2016
Epidemiological Cutoff Values for Antifungal Susceptibility Testing
Clinical and Laboratory Standards Institute document M59 - Epidemiological Cutoff Values for Antifungal Susceptibility Testing includes the epidemiological cutoff value (ECV) and QC tables developed...

References

This document references:
CLSI M57 - Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing
Published by CLSI on April 1, 2016
This guideline specifies requirements and recommendations for developing and using epidemiological cutoff values (ECVs) in antifungal susceptibility testing. The guideline’s intended users are...
This document is referenced by:
CLSI M23 - Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters
Published by CLSI on January 1, 2018
This guideline provides direction for determining breakpoints and QC parameters for antimicrobial agents that have a direct action on microorganisms. The intended audience includes sponsors (eg,...
This document is referenced by:
CLSI M38 - Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi
Published by CLSI on November 1, 2017
This standard describes the reference broth microdilution testing method for antifungal susceptibility testing of filamentous fungi (moulds) that cause invasive and/or cutaneous fungal...
This document is referenced by:
CLSI M27 - Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts
Published by CLSI on November 1, 2017
This standard describes a reference method for testing susceptibility to antifungal agents of yeasts that cause infections, including Candida spp. and Cryptococcus spp. The intended users are...
This document is referenced by:
CLSI M27 - Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts
Published by CLSI on November 1, 2017
This standard describes a reference method for testing susceptibility to antifungal agents of yeasts that cause infections, including Candida spp. and Cryptococcus spp. The intended users are...
This document is referenced by:
CLSI M38 - Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi
Published by CLSI on November 1, 2017
This standard describes the reference broth microdilution testing method for antifungal susceptibility testing of filamentous fungi (moulds) that cause invasive and/or cutaneous fungal...
This document is referenced by:
CLSI M60 - Performance Standards for Antifungal Susceptibility Testing of Yeasts
Published by CLSI on June 1, 2020
Clinical and Laboratory Standards Institute document M60—Performance Standards for Antifungal Susceptibility Testing of Yeasts includes minimal inhibitory concentration, zone diameter, and quality...
This document is referenced by:
CLSI M61 - Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi
Published by CLSI on June 1, 2020
Clinical and Laboratory Standards Institute document M61—Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi includes minimal inhibitory concentration and quality control...
View Less
View All
Advertisement